https://www.selleckchem.com/pr....oducts/actinomycin-d
- 0.12, 95% CI - 0.25 to - 0.01; p = 0.07, DES (MD - 0.12, 95% CI - 0.30 to 0.06; p = 0.18, and RQLQ (MD - 0.10, 95% CI - 0.28 to 0.08; p = 0.29. Combined montelukast and OAH was superior to montelukast in improving DNS (MD 0.15, 95% CI 0.08-0.21; p 0.001), NNS (MD 0.05, 95% CI - 0.09 to 0.19; p = 0.51, CSS (MD 0.1, 95% CI 0.03-0.17; p = 0.007), DES (MD 0.18, 95% CI 0-0.36; p = 0.05, and RQLQ (MD 0.07 95% CI - 0.15 to 0.29; p = 0.53. Montelukast is more effective than placebo in treating the overall symptoms of al
Mi piace
Commento
Condividi
